Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro

Advances in Nanoparticle-based Delivery of Next Generation Peptide Nucleic Acids

(2019) Shipra Malik et al.   CURRENT PHARMACEUTICAL DESIGN

Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma

(2019) Young-Eun Seo et al.   BIOMATERIALS

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

(2018) Merrill D. Benson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma

(2018) Anita G. Seto et al.   BRITISH JOURNAL OF HAEMATOLOGY

Alnylam launches era of RNAi drugs

(2018) Ken Garber   NATURE BIOTECHNOLOGY

Applications of PNA-laden nanoparticles for hematological disorders

(2018) Shipra Malik et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy

(2017) David R Corey   NATURE NEUROSCIENCE

Nanotechnology for delivery of peptide nucleic acids (PNAs)

(2016) Anisha Gupta et al.   JOURNAL OF CONTROLLED RELEASE

miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL)

(2016) P. Fava et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Incorporating Fatty Acid-Modified Polyethylenimine

(2014) Zhihua Guo et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

(2014) Fritz Eckstein   Nucleic Acid Therapeutics

Modified Poly(lactic-co-glycolic Acid) Nanoparticles for Enhanced Cellular Uptake and Gene Editing in the Lung

(2014) Rachel J. Fields et al.   Advanced Healthcare Materials

HCV Infection and Miravirsen

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas

(2012) Y. Zhang et al.   BLOOD

MicroRNAs Regulate Expression of Oncogenes

(2012) F. J. Slack   CLINICAL CHEMISTRY

Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery

(2012) Rachel J. Fields et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

(2012) I. A. Babar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Silencing of microRNA families by seed-targeting tiny LNAs

(2011) Susanna Obad et al.   NATURE GENETICS

High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization

(2010) Dongmei Cun et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

MicroRNA reexpression as differentiation therapy in cancer

(2009) Prasun J. Mishra et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA in Cancer Prognosis

(2008) Frank J. Slack et al.   NEW ENGLAND JOURNAL OF MEDICINE